Primary HIV

Sexually Transmitted Infections

Volumn 82, Issue 4, 2006, Pages 267-268

  Fox, Julie ^a   Weber, J ^a   Fidler, S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL TRIAL; COUNSELING; DISEASE COURSE; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIMARY INFECTION; PRIORITY JOURNAL; PROGNOSIS; VIRUS TRANSMISSION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COUNSELING; HIV INFECTIONS; HIV-1; HUMANS; PROGNOSIS;

EID: 33747189811     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2006.019877     Document Type: Editorial

References (24)

1. Fidler S, Fraser C, Fox J, et al. Comparative potency of three antiretroviral therapy regimes in primary HIV infection. AIDS 2006;20:247-52.
2. Hammer SM. Clinical practice. Management of newly diagnosed HIV infection. N Engl J Med 2005;353:1702-10. Review.
3. Blattner W, Ann Oursler K, Cleghorn F, et al. Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS. J Infect Dis 2004;189:1793-801.
4. Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis of HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
5. Pedersen C, Lindhardt BO, Jensen BL, et al. Clinical course of primary HIV infection: consequences for subsequent course of infection. BW 1989;299:154-7.
6. Keet IPM, Krijnen P, Koot M, et al. Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS 1993;7:51-7.
7. Sinicco A, Fora R, Sciandra M, et al. Risk of developing AIDS after primary acute HIV-1 infection. J Acquir Immune Defic Syndr 1993;6:575-81.
8. 6/I, AIDS and death from AIDS? BMJ 1994;309:1535-7.
9. Veugelers PJ, Kaldor JM, Strathdee SA, et al. Incidence and prognostic significance of symptomatic primary human immunodeficiency virus type 1 infection in homosexual men. J Infect Dis 1997;176:112-17.
10. Boufassa F, Bachmeyer C, Carre N, et al. Influence of neurologic manifestations of primary human immunodeficiency virus infection on disease progression. SEROCO Study Group. J Infect Dis 1995;171:1190-5.
11. Lyles RH, Munoz A, Yamashita TE, et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. J Infect Dis 2000;181:872-80.
12. Bonetti A, Weber R, Vogt MW, et al. Co-infection with human immunodeficiency virus-type 1 (HIV-1) and cytomegalovirus in two intravenous drug users. Ann Intern Med 1989;111:293-6.
13. Raffi F, Boudart D, Billaudel S. Acute co-infection with human immunodeficiency virus (HIV) and cytomegalovirus. Ann Intern Med 1990;112:234.
14. Collaborative Group on AIDS Incubation and HIV Survival. Time from HIV-1 seroconversion to AIDS and death before the widespread use of highly active anti-retroviral therapy: a collaborative re-analysis. Lancet 2000;355:1131-7.
15. BHIVA. Writing committee on behalf of the BHIVA Executive Committee. The BHIVA treatment Guidelines for 2005 http://www.bhiva.org/guidelines/2005/BHIVA- guidelines/.
16. Smith DE, Walker BD, Cooper DA, et al. Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence? AIDS 2004;18:709-18
17. Meerssemon W, Van Laethem K, Lagrou K, et al. Fatal brain necrosis in primary HIV infection. Lancet 2005;366:866.
18. Niu MT, Stein DS, Schnittman SM. Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections. J Infect Dis 1993;168:1490-501, Review.
19. Kaufmann D, Lichterfeld M, Altfeld M, et al. Limited durability of viral control following treated acute HIV infection. Plos Med 2004;1:e36.
20. Fox J, Scriba T, Oxenius A, et al. HIV-specific immune responses fail to predict CD4 decline or clinical outcome following treatment at primary HIV-1 infection. Abstract No I-106. The 13th Conference on Retroviruses and Opportunistic infections, 2006.
21. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921-9.
22. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005;191:1403-9. Epub 2005 Mar 30.
23. Koopman JS, Jacquez JA, Welch GW, et al. The role of early HIV infection in the spread of HIV through populations. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:249-58.
24. Fox J, McClure M, Weber J, et al. Risk factors for the acquisition of HIV in individuals known to have recently seroconverted. BHIVA Conf 2005 Apr 20-23;11:O15.